Novartis AG (XSWX:NOVNEE) Cash Flow for Dividends : CHF-6,787 Mil (TTM As of Sep. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Novartis AG Cash Flow for Dividends?

Novartis AG's cash flow for dividends for the three months ended in Sep. 2024 was CHF0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2024 was CHF-6,787 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Novartis AG's quarterly payment of dividends declined from Mar. 2024 (CHF-4,627 Mil) to Jun. 2024 (CHF-2,160 Mil) and declined from Jun. 2024 (CHF-2,160 Mil) to Sep. 2024 (CHF0 Mil).

Novartis AG's annual payment of dividends increased from Dec. 2021 (CHF-6,786 Mil) to Dec. 2022 (CHF-6,993 Mil) but then declined from Dec. 2022 (CHF-6,993 Mil) to Dec. 2023 (CHF-6,274 Mil).

Novartis AG Cash Flow for Dividends Historical Data

The historical data trend for Novartis AG's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Cash Flow for Dividends Chart

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

-6,529.38

-6,207.25

-6,785.93

-6,992.59

-6,274.12

Novartis AG Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-4,626.94	-2,160.32	-

Novartis AG Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-6,787 Mil.

Novartis AG Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Novartis AG's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (XSWX:NOVNEE) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NVS:USA NVS N:Mexico NOVNz:UK 0K9E:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines